JESSICA TOMMERUP: Open Payments
NPI 1114225067 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 43 payments from 14 companies in 2025. Trend: 2023 $210 · 2024 $1,146 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $305 |
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| Novo Nordisk Inc | 6 | $130 |
| HEARTFLOW, INC. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $30 |
Products named: WATCHMAN Access System, Wegovy, FFRct, LEQVIO, Kerendia, WAINUA, CARDIOMEMS, AMVUTTRA.
Industry payments across WI — which companies pay providers there.
